Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
323 2 |
Ultima descărcare din IBN: 2023-06-26 11:16 |
Căutarea după subiecte similare conform CZU |
616.98:578.834.1-036.82(478) (1) |
Boli transmisibile. Boli infecţionase şi contagioase, stări febrile (585) |
Virologie (443) |
SM ISO690:2012 CEBOTARI, Ecaterina, GROSU, Oxana, OLOERI, Mihail, BĂITOI, Silvia, CORCEA, Galina, ODOBESCU, Stela. Persistent post COVID symptoms in patients with neurological manifestations: results of the energy registry in the Republic of Moldova. In: Revista de Ştiinţe ale Sănătăţii din Moldova, 2022, nr. 3 An.1(29), p. 271. ISSN 2345-1467. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Revista de Ştiinţe ale Sănătăţii din Moldova | ||||||
Numărul 3 An.1(29) / 2022 / ISSN 2345-1467 | ||||||
|
||||||
CZU: 616.98:578.834.1-036.82(478) | ||||||
Pag. 271-271 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Introduction. COVID 19 infection predisposes to major consequences over time named Long COVID or Post-COVID syndrome with a major social and economic impact. Objectives. Analysis of post-COVID symptoms in patients who have experienced neurological manifestations during COVID infection. Materials and methods. The study was performed on 169 patients, collected according to the ENERGY protocol between the years 2020-2022, which represents the cohort from the Republic of Moldova. For the acute infection stage, the electronically structured questionnaire was completed and for the post-COVID monitoring period, the patients were interviewed by telephone every 6 months. Results. The general research group comprised 50.3% men and women 49.7%, the mean age of 65.8 ± 13.87 years. 71 patients responded to the interviews, with an average of 2.4 ± 0.51 follow-up visits. Number of patients with at least 1 persistent symptom during the follow-up visit - 42.0%, the most common being: fatigue = 17.2%, drowsiness = 8.3%, insomnia = 5.9%, headache = 14.2%, pain = 7.1%, concentration and memory deficit = 11.2%, depression = 11.8%, anxiety = 11.2% dyspnea = 3.6%, numbness = 8.9%, palpitations = 10.1% and chest pain = 3.0%. The modified Rankin scale was 3.29 ± 1.4 points. Two patients (1.2%) developed stroke repeatedly and one patient (0.6%) developed myelopathy during the observation period. They mentioned the very low quality of life - 7.1%. Conclusions. Patients who had COVID infection with neurological manifestations, showed in 42 % of cases persistent symptoms, such as fatigue, headache, concentration disturbances, depression, and anxiety. |
||||||
Cuvinte-cheie Post COVID syndrome, persistent symptoms, quality of life, Sindrom post COVID, simptome persistente, Calitatea vieţii |
||||||
|